Covid-19 update: Hard copy Optimise materials are prepared and distributed at CPPE head office which is currently closed. Digital materials can be downloaded on the page for each topic under Facilitator's resources.
This programme consists of a combination of interactive, online and small group learning activities. Click through the screens to complete the programme.
The Best-value biological medicines: Focus on the position of biosimilar medicines Optimise programme assumes you have some prior knowledge of the topic area. You may wish to watch the two short videos below to revise your knowledge before you start the Optimise programme.
Once you have completed the programme, or if you want to skip this section, click Next to continue.
Dale Arm-Riding, patient
Idris Bobat, pharmacy homecare lead and medication safety, Gloucestershire Hospitals NHS Foundation Trust
Stephen Brown, regional pharmacist, NHS England/NHS Improvement, South West and South East England
Anna Pracz, senior medicines optimisation pharmacist, Greater Manchester Health and Care Commissioning
Vanessa Reid, lead specialist clinical pharmacist, specialist medicine (dermatology, immunology, gastroenterology and rheumatology), Manchester University Foundation Trust
Caron Underhill, biologics pharmacist, University Hospital Southampton NHS Foundation Trust
CPPE programme developer
Liz Reid, lead pharmacist, learning development
Samantha White, deputy director
Karen Wragg, regional manager, South Central
Clare Hardy, senior pharmacist – biologics, Chesterfield Royal Hospital NHS Foundation Trust
Sally James, divisional lead pharmacist for unscheduled care, Royal Liverpool University Hospital
Paddy McLaughlin, editor
Alison Fryer, Salford Royal NHS Foundation Trust
Bilal Jabbar, Avicenna Medical Practice, Bradford
Brand names and trademarks
CPPE acknowledges the following brand names and registered trademarks mentioned throughout this update: Benepali ®, Enbrel ®, Hulio ®, Humira ®